Tag Archives: deal

FiercePharmaAsia—Takeda’s dengue shot; Pfizer’s China Ibrance deal; Aslan job cuts

Takeda’s dengue vaccine is getting closer to challenging Sanofi’s Dengvaxia as the Japanese drugmaker announced the shot met its goals in a large phase 3 trial. Pfizer introduced an alternative payment scheme to China’s oncology market with a pay-for-performance deal on Ibrance. Aslan plans steep job cuts after its lead candidate failed in gastric cancer. And more. 1. Takeda’s… Read More »